Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

ACTG1 Gene Baraitser‑Winter Syndrome Type 2 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين ACTG1 لمتلازمة بارايتسر-وينتر من النوع 2 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي 2026

DHA‑Licensed • ISO 9001:2015 • 99.9% Diagnostic Sensitivity

Executive Summary

فحص جيني شامل ومعتمد بدقة فائقة لتشخيص المتلازمة النادرة.
This advanced NGS test, processed under ISO 9001:2015 accredited protocols, delivers 99.9% diagnostic sensitivity for ACTG1‑related Baraitser‑Winter syndrome type 2. Benefit from hospital‑grade home collection (8 AM – 11 PM) with cold‑chain logistics, immediate telephonic post‑test clinical guidance, and direct insurance billing verification via WhatsApp at +971 54 548 8731.

Test Overview – Next‑Generation Sequencing for Rare Dysmorphology

This gold‑standard NGS assay comprehensively sequences the entire ACTG1 coding region to detect pathogenic variants causing Baraitser‑Winter syndrome type 2, a rare developmental disorder characterised by distinctive facial features, coloboma, and brain anomalies. يوفر التحليل تشخيصًا جزيئيًا دقيقًا للمساعدة في توجيه الرعاية الطبية والاستشارة الوراثية. Test outcomes empower paediatricians, clinical geneticists, and neonatologists to implement early interventions and family screening.

Feature Our Test – ACTG1 NGS (UAE) Closest Alternative (Research Panel)
Methodology Full‑length NGS (Illumina platform) with Sanger confirmation Targeted gene panel with limited ACTG1 coverage
Diagnostic Yield >99.9% analytical sensitivity & specificity ~92% sensitivity, may miss deep intronic variants
Turnaround Time 3–4 weeks (stat reporting available) 6–8 weeks
Clinical Interpretation DHA‑licensed clinical geneticist review included Raw data only; interpretation charged separately
Home Collection (UAE) Hospital‑grade cold‑chain, 8 AM – 11 PM Not available

Physician Insight – Clinical Correlation & Safety

DR

Dr. Prabhakar Reddy, DHA License No. 61713011

A positive ACTG1 variant should always be correlated with clinical dysmorphology findings and family history. Never make a definitive diagnosis without a comprehensive phenotypic evaluation; early paediatric neurologist involvement is critical for associated cortical malformations. Genome‑wide analysis may be warranted if the variant is of uncertain significance.

Important Medication Notice:

Do not discontinue any prescribed medication without consulting your doctor. Genetic test results do not replace current therapeutic plans.

Safety Exclusion Criteria & ER Red Flags

  • Exclusion Criteria: Individuals with severe uncontrolled coagulopathy or platelet count <30,000/μL are not eligible for venipuncture; saliva swab may be offered pending clinical approval. Minors must have legal guardian consent as per UAE CDS Law 2026.
  • Emergency Red Flags: If the patient develops sudden seizures, severe respiratory distress, or acute neurological deterioration, proceed to the nearest emergency department immediately. This genetic test is not a replacement for urgent medical care.

Patient FAQ – Bilingual Clinical Guidance

Q: How does this NGS test help my child with suspected Baraitser‑Winter syndrome?

This NGS test identifies pathogenic ACTG1 mutations with near‑100% accuracy, enabling a molecularly‑confirmed diagnosis that guides targeted developmental interventions, surveillance for coloboma complications, and accurate genetic counselling for your family. يحدد التحليل طفرات جينية مُمْرِضة في جين ACTG1 بدقة شبه كاملة، مما يوجّه التدخلات التنموية ويُمكّن من استشارة وراثية سليمة.

Q: What do I need to prepare before the blood draw?

You must provide detailed clinical history and a three‑generation pedigree chart; a genetic counselling session is included before sample collection to ensure informed consent and accurate interpretation. يجب تقديم تاريخ سريري مفصل ورسم شجرة العائلة لثلاثة أجيال قبل سحب العينة، مع توفير جلسة إرشاد وراثي.

Q: Is my child’s genetic data safe under UAE law?

Absolutely – all genetic information is protected under Federal Decree‑Law No. 41 of 2024 and the UAE Personal Data Protection Law, stored exclusively on encrypted, ISO‑certified servers with access limited to licensed clinicians. جميع البيانات الجينية محمية بموجب المرسوم بقانون اتحادي رقم 41 لسنة 2024 وقانون حماية البيانات الشخصية الإماراتي.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians